Former Chief Financial Officer · PALVELLA THERAPEUTICS, INC. (PVLA)

Thomas Bures

A named executive officer of PALVELLA THERAPEUTICS in every fiscal year CompBrief holds from FY2019 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$943,699

Salary $383,482Stock awards $0

FY2023: $729,037

5th of 5 named executive officers at Palvella Therapeutics by FY2024 total.

5 named officers on file for PALVELLA THERAPEUTICS, FY2024

Thomas Bures’s pay file — $29

  • 5 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how PALVELLA THERAPEUTICS’s whole pay program stands against its peers

  • PALVELLA THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PVLA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2025 (DEF 14A).

Free

Get Thomas Bures’s full pay file as a PDF — free

More than this page: up to 10 years of Thomas’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Thomas Bures compensation by year

PALVELLA THERAPEUTICS Summary Compensation Table · all 5 fiscal years held
In US dollars, as PALVELLA THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2022FY2023FY2024
Salary$257,500$283,250$381,100$400,155$383,482
Bonus$0$0$0$80,031$0
Stock awards$0$0$0$0$0
Option awards$152,938$154,038$444,183$241,536$0
Non-equity incentive$66,242$65,856$106,078$0$0
Pension and deferred compensation$0$0$0$0$0
All other$0$11,400$12,200$7,315$560,217
Total$476,680$514,544$943,561$729,037$943,699

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: PALVELLA THERAPEUTICS, INC. DEF 14A filed April 30, 2025, accession 0001104659-25-042493, and prior-year filings.

How this page was built: the PALVELLA THERAPEUTICS, INC. filed document, accession 0001104659-25-042493. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2025.

$477K
$515K
$944K
$729K
$944K
FY19
FY20
FY22
FY23
FY24
SalaryBonusNon-equity incentiveOption awardsAll other

PALVELLA THERAPEUTICS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Wesley KaupinenPresident and Chief Executive Officer$5,436,064
Jeffrey MartiniChief Scientific Officer$1,866,763
Stephen YoderFormer Chief Executive Officer$1,426,204
Kathleen GoinChief Operating Officer$1,124,572
Thomas Bures · this pageFormer Chief Financial Officer$943,699

The full PALVELLA THERAPEUTICS compensation record

free company brief

This page is one person within PALVELLA THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are PALVELLA THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Thomas Bures's compensation dossier · One-time report. No refunds.